Главная
Study mode:
on
1
Introduction
2
Final Recommendation
3
High Bleeding Risk
4
Summary
5
Practical Tips
6
Best P212 Agent
7
Deescalation
8
Why are you deescalate
9
Is there good data
10
Practical tip
11
Atal prolation
12
Augustus study
13
Stemi
14
Notic
15
Longterm
16
CPO
17
ACS
18
Controversies
19
International Guidelines Committee
20
Questions
Description:
Explore the latest updates on antiplatelet therapy guidelines in this 57-minute cardiology rounds presentation. Dive deep into the 2023 CCS/CAIC Focus Update with Dr. Derek So, a staff cardiologist, clinical investigator, and associate professor at the University of Ottawa Heart Institute. Gain insights into final recommendations, high bleeding risk considerations, and practical tips for implementation. Examine the best P2Y12 agents, de-escalation strategies, and the rationale behind them. Analyze key studies like AUGUSTUS and their implications for STEMI patients. Discuss long-term management of NSTEMI-ACS and address current controversies in the field. Engage with the International Guidelines Committee's perspective and participate in a Q&A session to enhance your understanding of antiplatelet therapy in cardiovascular care.

Update on the 2023 CCS/CAIC Guidelines for Antiplatelet Therapy - A Deeper Dive

University of Ottawa Heart Institute
Add to list
0:00 / 0:00